Novartis reports two heart drugs are safe, effective

Article Abstract:

Novartis AG of Switzerland has two heart disease drugs that lower blood pressure showing promise in research. Both Rasilez and Exforge are in the process of approval by the United States Food and Drug Administration and European authorities. Rasilez is expected to generate sales of $1 billion and Exforge, $500 million per year.

United States, Europe, Product development, Pharmaceutical preparations, Pharmaceutical industry, Novartis AG, NVTSY, Exforge (Medication), Rasilez (Medication)

---

Davos weighs new forum to boost China's presence

Article Abstract:

The World Economic Forum conference held in Davos, Switzerland is to focus on the emerging economies of India and China. However, the timing of the economic conference coincided with Chinese Lunar New Year so another conference may be held in China at a later date.

China, India, Sales Meetings, Conferences, meetings and seminars, Conferences and conventions, Davos, Switzerland, World Economic Forum

---

Swiss Re names former official of Federal Reserve to its board

Article Abstract:

Roger W. Ferguson Jr. has been appointed a member of the board at Swiss Reinsurance Co. and chairman of Swiss Re America Holding. Mr. Ferguson Jr. is formerly of the United States Federal Reserve Board and resigned from this position in April 2006.

Executive changes & profiles, INSURANCE CARRIERS, Officials and employees, Insurance industry, Appointments, resignations and dismissals, Biography, Swiss Reinsurance Co., Ferguson, Roger W.

Similar abstracts:

• Abstracts: Italy's Central Banker feels the heat for foreign mergers. Draghi is named chief of Italy's central bank. Italy's top banker steps down as probes intensify
• Abstracts: Can an itsy-bitsy auto survive in the land of the SUV? Potential buyer Magna set to visit Chrysler. Hyundai Shuffles CEOs in U.S
• Abstracts: Europe may offer a glimpse into future of U.S. Exchange. Bank of America hires Goldman Sachs veteran. Turkey's banking market lures lenders seeking growth

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.